PIH10 COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA

Abstract

Authors

X. Sun X. Hu X. Zhen Y. L.I. Y. Gu Z. Zhao H. Dong

Full Text Cite This Article
Back to Volume 23, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×